This inventor holds 2 USPTO granted patents. Top assignee: National Tsing Hua University. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Innovations of Inventor Hung-Lun Chu
Introduction
Hung-Lun Chu is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of peptides with various therapeutic applications. With a total of 2 patents, his work focuses on addressing critical health challenges through innovative solutions.
Latest Patents
Among his latest patents, Hung-Lun Chu has developed an anti-endotoxin polypeptide. This polypeptide is designed to neutralize lipopolysaccharides, exhibiting low hemolysis and high salt resistance. The formula of the anti-endotoxin polypeptide includes a short peptide with α-helix structure, which is crucial for its functionality. Additionally, he has created peptides with antimicrobial, anticancer, and wound-healing promoting activities. These peptides consist of an α-helix peptide connected to a short peptide of positively charged amino acids, enhancing their therapeutic potential.
Career Highlights
Hung-Lun Chu is affiliated with National Tsing Hua University, where he continues to engage in groundbreaking research. His work not only contributes to academic knowledge but also has practical implications in the medical field. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
He collaborates with esteemed colleagues, including Hui-Yuan Yu and Jya-Wei Cheng. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Hung-Lun Chu's contributions to biotechnology through his patents and research exemplify the importance of innovation in addressing health-related challenges. His work continues to inspire advancements in therapeutic applications.